Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical photodynamic therapy for localized scleroderma.

S Karrer1, C Abels, M Landthaler

  • 1Department of Dermatology, University of Regensburg, Germany.

Acta Dermato-Venereologica
|March 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum: Integration of digital health applications into the German healthcare system: development of "The DiGA-Care Path".

Frontiers in health services·2024
Same author

Integration of digital health applications into the German healthcare system: development of "The DiGA-Care Path".

Frontiers in health services·2024
Same author

Assessment of innovative living and care arrangements for persons with dementia: a systematic review.

BMC geriatrics·2023
Same author

Pharmacokinetic profile data of glycopyrronium bromide 1% cream beyond 2 weeks are important: reply from the authors.

The British journal of dermatology·2021
Same author

A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial.

The British journal of dermatology·2021
Same author

Hyperhidrosis Quality of Life Index (HidroQoL©): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial.

The British journal of dermatology·2020

Topical photodynamic therapy (PDT) shows promise for treating localized scleroderma when conventional methods fail. This therapy effectively reduced sclerotic plaques with minimal side effects, warranting further investigation.

Area of Science:

  • Dermatology
  • Photomedicine

Background:

  • Localized scleroderma treatment remains challenging, with existing therapies offering limited efficacy and significant side effects.
  • Novel therapeutic approaches are needed for progressive localized scleroderma.

Purpose of the Study:

  • To evaluate the effectiveness of topical photodynamic therapy (PDT) for localized scleroderma.
  • To assess PDT as a treatment option for patients unresponsive to conventional therapies.

Main Methods:

  • A pilot study involving five patients with progressive localized scleroderma.
  • Treatment involved topical 5-aminolevulinic acid gel followed by incoherent lamp irradiation.
  • Therapy was administered once or twice weekly for 3-6 months.

Main Results:

Related Experiment Videos

  • All patients demonstrated high effectiveness in treating sclerotic plaques, confirmed by durometer and clinical skin scores.
  • The only reported side effect was transient hyperpigmentation of treated areas.
  • No significant adverse events were observed.

Conclusions:

  • Topical photodynamic therapy is a potentially beneficial treatment for localized scleroderma.
  • Preliminary findings suggest PDT is effective and well-tolerated.
  • Further controlled clinical trials are required to validate these results.